Skip to main content
. Author manuscript; available in PMC: 2018 Jan 25.
Published in final edited form as: J Neurooncol. 2017 Nov 9;136(2):289–298. doi: 10.1007/s11060-017-2652-0

Fig. 3.

Fig. 3

Comparison of symptomatic radiation necrosis for patients treated with angiotensin blockade therapy (ABT) and stereotactic radiosurgery (SRS) to SRS alone. Competing risk model is utilized for resected brain metastases patients (a) and Kaplan Meier model for AVM patients (b)